tiprankstipranks
Trending News
More News >
Mydecine Innovations Group (TSE:MYCO)
:MYCO
Canadian Market

Mydecine Innovations Group (MYCO) Income Statement

Compare
99 Followers

Mydecine Innovations Group Income Statement

Last quarter (Q3 2024), Mydecine Innovations Group's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Mydecine Innovations Group's net income was $-1.99M. See Mydecine Innovations Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ 7.49K$ 2.62K$ 31.52K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 9.88K$ 128.86K$ 235.18K$ 57.08K$ 46.39K
EBITDA
$ -19.63M$ -16.20M$ -23.14M$ -26.64M$ -21.30M
Operating Income
$ -9.55M$ -16.39M$ -22.68M$ -11.46M$ -3.39M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -20.95M$ -11.57M$ -28.90M$ -26.95M$ -21.43M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Mydecine Innovations Group Earnings and Revenue History